APIs and Formulated Products CDMO Addresses Industry Challenges at Speaker’s Corner

Aesica is a leading global full-service provider, establishing long-term strategic partnerships with its clients, responding quickly and effectively to market demand and developing tailored solutions for specific requirements. As a fast growing CDMO, Aesica currently employs 1,300 skilled personnel with development and manufacturing sites located in Cramlington, Newcastle, Nottingham and Queenborough in the UK, Zwickau and Monheim in Germany and Pianezza in Italy.

One of Aesica’s key values is its awareness that customers want more than a supplier, which is why the company works in partnership to provide a flexible, efficient and reliable service.

Aesica provides services that stem the entire product lifecycle, from the manufacture of APIs, formulation and development for clinical trials to large-scale commercial manufacturing. The company offers global supply and delivery combined with regional expertise and understanding.

Aesica will be running a drinks reception on Tuesday 22 and Wednesday 23 October 2013, from 4–5:30 pm, at its stand, where visitors can learn more about the company’s services, including particular areas of specialism such as continuous tablet processing, inhalation and potent drug capabilities.

This year, Aesica will be providing key insights into its offering and how specific industry challenges are overcome at CPhI’s Speaker’s Corner. Join Aesica on Wednesday 23 October at 10 am for an informative session on ‘Trends in Abuse Resistant Formulations and Continuous Tablet Processing’.

Stand 42D09

Aesica Pharmaceuticals Ltd, +44 191 218 1960, weshouldtalk@aesica-pharma.com, www.aesica-pharma.co.uk.